— Financial reporting — Consolidated balance sheet
Consolidated balance sheet
|
millions of CHF |
|
Notes |
|
June 30, 2023 |
|
December 31, 2022 |
|
June 30, 2022 1) |
|
Non-current assets |
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
253.3 |
|
254.4 |
|
252.1 |
|
Other intangible assets |
|
|
|
110.5 |
|
120.4 |
|
123.3 |
|
Property, plant and equipment |
|
|
|
180.6 |
|
157.6 |
|
145.5 |
|
Lease assets |
|
|
|
70.4 |
|
72.1 |
|
74.3 |
|
Non-current financial assets |
|
|
|
8.4 |
|
6.5 |
|
12.0 |
|
Non-current receivables |
|
|
|
0.1 |
|
0.1 |
|
0.0 |
|
Deferred income tax assets |
|
|
|
7.9 |
|
5.8 |
|
3.3 |
|
Total non-current assets |
|
|
|
631.1 |
|
617.0 |
|
610.5 |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
Inventory |
|
|
|
97.4 |
|
91.8 |
|
82.2 |
|
Current income tax receivables |
|
|
|
– |
|
0.0 |
|
0.0 |
|
Advance payments to suppliers |
|
|
|
3.6 |
|
4.0 |
|
8.4 |
|
Contract assets |
|
|
|
2.2 |
|
1.0 |
|
0.4 |
|
Trade accounts receivable |
|
|
|
66.6 |
|
59.6 |
|
49.2 |
|
Other current receivables and prepaid expenses |
|
|
|
18.1 |
|
15.8 |
|
16.7 |
|
Current financial assets |
|
|
|
7.1 |
|
3.3 |
|
– |
|
Cash and cash equivalents |
|
|
|
145.6 |
|
313.5 |
|
188.9 |
|
Total current assets |
|
|
|
340.4 |
|
489.0 |
|
345.8 |
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
|
971.6 |
|
1’105.9 |
|
956.2 |
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
Share capital |
|
|
|
0.4 |
|
0.4 |
|
0.4 |
|
Reserves |
|
|
|
486.5 |
|
504.4 |
|
502.6 |
|
Equity attributable to shareholders of medmix Ltd |
|
8 |
|
486.9 |
|
504.8 |
|
503.1 |
|
Total equity |
|
8 |
|
486.9 |
|
504.8 |
|
503.1 |
|
|
|
|
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
|
|
|
Non-current borrowings |
|
9 |
|
247.0 |
|
246.9 |
|
226.7 |
|
Non-current lease liabilities |
|
|
|
59.6 |
|
62.5 |
|
65.2 |
|
Deferred income tax liabilities |
|
|
|
14.6 |
|
16.1 |
|
18.2 |
|
Non-current income tax liabilities |
|
|
|
– |
|
– |
|
0.8 |
|
Defined benefit obligations |
|
|
|
1.0 |
|
1.0 |
|
1.5 |
|
Non-current provisions |
|
|
|
3.7 |
|
3.6 |
|
3.8 |
|
Other non-current liabilities |
|
|
|
11.2 |
|
– |
|
0.1 |
|
Total non-current liabilities |
|
|
|
337.0 |
|
330.0 |
|
316.2 |
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
Current borrowings |
|
9 |
|
0.3 |
|
155.1 |
|
21.7 |
|
Current lease liabilities |
|
|
|
9.7 |
|
9.0 |
|
9.0 |
|
Current income tax liabilities |
|
|
|
5.4 |
|
4.7 |
|
7.8 |
|
Current provisions |
|
|
|
4.7 |
|
5.7 |
|
5.4 |
|
Contract liabilities |
|
|
|
3.6 |
|
3.9 |
|
3.2 |
|
Trade accounts payable |
|
|
|
65.7 |
|
47.4 |
|
43.0 |
|
Other current and accrued liabilities |
|
10 |
|
58.2 |
|
45.2 |
|
46.9 |
|
Total current liabilities |
|
|
|
147.6 |
|
271.1 |
|
137.0 |
|
Total liabilities |
|
|
|
484.6 |
|
601.1 |
|
453.2 |
|
|
|
|
|
|
|
|
|
|
|
Total equity and liabilities |
|
|
|
971.6 |
|
1’105.9 |
|
956.2 |
1) The numbers as of June 30, 2022, have been adjusted following the deconsolidation of medmix Poland. A reconciliation to the previously published numbers is provided in note 14.